← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2011Last known activity
May 1, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 6 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT06703411Lead sponsorPhase 4May 1, 2023
- NCT06703411Sponsor investigatorPhase 4May 1, 2023
- NCT04575675Reponsible party - principal investigatorPhase 4May 29, 2020
- NCT04575675Overall official - principal investigatorPhase 4May 29, 2020
- NCT04575675Lead sponsorPhase 4May 29, 2020
- NCT04502264Lead sponsorPhase 2Jan 9, 2020
- NCT06886620OfficialPhase 3Mar 14, 2016
- NCT04088474Overall official - principal investigatorN/AMar 5, 2016
- NCT01710007Overall official - principal investigatorPhase 3Nov 1, 2011
Details
- Last known activity
- May 1, 2023